maprotiline has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT; Chen, JS; Chen, WC; Cheng, HH; Ho, CM; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Lo, YK | 1 |
| Chang, HT; Chen, JS; Chen, WC; Cheng, HH; Cheng, JS; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Lo, YK; Yeh, JH | 1 |
2 other study(ies) available for maprotiline and thapsigargin
| Article | Year |
|---|---|
Effect of the antidepressant maprotiline on calcium movement and the viability of renal tubular cells.
Topics: Animals; Antidepressive Agents, Second-Generation; Calcium; Calcium Signaling; Cell Line; Cell Survival; Dogs; Enzyme Inhibitors; Estrenes; Fluorescent Dyes; Fura-2; Kidney Tubules; Maprotiline; Phosphodiesterase Inhibitors; Pyrrolidinones; Thapsigargin; Type C Phospholipases | 2004 |
Effect of maprotiline on Ca(2+) movement in human neuroblastoma cells.
Topics: Biological Transport, Active; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Fura-2; Humans; Maprotiline; Nifedipine; Thapsigargin; Time Factors; Tumor Cells, Cultured; Type C Phospholipases; Verapamil | 2004 |